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Abstract
Background: Neocortical circuits are established through the formation of synapses between cortical neurons, but
the molecular mechanisms of synapse formation are only beginning to be understood. The mechanisms that
control synaptic vesicle (SV) and active zone (AZ) protein assembly at developing presynaptic terminals have not
yet been defined. Similarly, the role of glutamate receptor activation in control of presynaptic development
remains unclear.
Results: Here, we use confocal imaging to demonstrate that NMDA receptor (NMDAR) activation regulates
accumulation of multiple SV and AZ proteins at nascent presynaptic terminals of visual cortical neurons. NMDAR-
dependent regulation of presynaptic assembly occurs even at synapses that lack postsynaptic NMDARs. We also
provide evidence that this control of presynaptic terminal development is independent of glia.
Conclusions: Based on these data, we propose a novel NMDAR-dependent mechanism for control of presynaptic
terminal development in excitatory neocortical neurons. Control of presynaptic development by NMDARs could
ultimately contribute to activity-dependent development of cortical receptive fields.
Background
Synapse formation is a key step in the assembly of the
neural circuits that control perception and behavior. In
addition, impaired synapse formation may contribute to
abnormal development and pathogenesis of neurodeve-
lopmental disorders. Recent genetic and functional stu-
dies have linked synapse development to autism
spectrum disorders, cognitive impairment, epilepsy, schi-
zophrenia and depression [1,2].
During glutamatergic synapse formation in the central
nervous system, contact between an axon and a dendrite
induces a cascade of events, ultimately resulting in for-
mation of a presynaptic terminal and postsynaptic den-
sity at the site of contact. As an integral part of this
process, the proteins required for regulated transmitter
release must be accumulated at the site of axo-dendritic
contact. It has been shown that transport vesicles deliver
s y n a p t i cv e s i c l e( S V )a n da c t i v ez o n e( A Z )p r o t e i n st o
developing presynaptic terminals [1,3,4]. Formation of
the AZ is then thought to be initiated by fusion of AZ
protein transport vesicles with the axonal surface [5].
SVs form within the nascent terminal or are acquired
from preassembled clusters of SVs that are mobile
within axons [6-9]. As a bouton continues to develop,
the number of SVs increases and the AZ expands,
requiring continual recruitment of SV and AZ proteins
[10]. The molecular signals that control accumulation of
SV and AZ proteins at nascent terminals remain incom-
pletely understood.
Although, the initial induction of synapse formation
occurs through trans-synaptic molecular interactions
[1,11] even in the absence of neurotransmitter release
and glutamate receptor activation, synaptic activity and
glutamate can modulate synaptic development [12-14].
For example, synaptic activation of NMDA receptors
(NMDARs) is sufficient to induce growth of new dendri-
tic spines and synapses [15-19]. In addition, knockdown
or knockout of postsynaptic NMDARs alters the density
and structural dynamics of dendritic spines and the accu-
mulation of postsynaptic scaffolding molecules at spines
[20-23], although changes in density may be at least par-
tially a result of altered dendrite growth and branching
[20,24]. Finally, activation of NMDARs regulates
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of NMDARs [25-27].
Although most previous studies have focused on the
role of glutamate receptors during postsynaptic develop-
ment, it is likely that glutamate receptors also control
presynaptic development since presynaptic and postsy-
naptic morphology and function are correlated [28,29].
For example, during early stages of circuit development,
synapses with high accumulation of postsynaptic markers
have high accumulation of presynaptic markers [28]. Reg-
ulation of presynaptic development by glutamate recep-
tors could occur through direct effects on presynaptic
terminals, possibly via presynaptic NMDARs [30,31], via
activation of postsynaptic receptors followed by retro-
grade signaling from postsynaptic dendrites to presynap-
tic terminals [32], or by cell-autonomous transneuronal
signaling from postsynaptic receptors to presynaptic
terminals [33-38].
Recent reports suggest that synaptic activity regulates
presynaptic terminal development. For example,
Munc18-1 knockouts that lack transmitter release have
decreased synapse density, synapses with docked SVs,
and number of SVs [39]. In another study, the total levels
of several SV proteins were decreased in the hippocam-
pus from mice with diminished glutamatergic transmis-
sion due to knockout of VGlut1 [40]. Finally, in Xenopus
optic tectum, bath application with the use-dependent
NMDAR inhibitor MK-801 leads to a decrease in the
percentage of presynaptic volume occupied by SVs [10].
Here, we used confocal fluorescence imaging to investi-
gate the role of NMDAR activation at developing presy-
naptic terminals. We find that activation of NMDARs
controls accumulation of both SV and AZ proteins at
nascent presynaptic terminals. This regulation occurs
even in the absence of retrograde signaling from postsy-
naptic NMDARs or glia. Based on these observations, we
suggest a model for synapse development in which
NMDARs directly regulate presynaptic terminal assem-
bly. This could provide a feed-back mechanism capable
of promoting development of active presynaptic term-
inals, even in the absence of postsynaptic activity.
Results
NMDA receptor activation regulates accumulation of
synaptic vesicle proteins during synapse formation
One of the earliest steps of presynaptic development is
obligatory recruitment of SV proteins to nascent
synapses. Therefore, to assess whether activation of
NMDA receptors plays a role in excitatory presynaptic
terminal development, neurons were treated with APV
(DL-2-amino-5-phosphonopentanoic acid) for 24 to 48 h
then fixed and immunolabeled with antibodies against
the SV-associated protein synapsin and imaged using
confocal microscopy (Figure 1A,B). To focus on early
stages of synapse assembly, neurons were treated at the
beginning of excitatory synapse formation, at 6 to 7 days
in vitro (DIV), then synapse development was assayed at
8 DIV. Simultaneous immunolabeling for tau-1 was used
to identify axons, and PSD95 labeling verified that synap-
sin was associated with synapses. Synapsin puncta were
identified using an automated image analysis algorithm
(see Materials and methods) and their fluorescence inten-
sities quantified.
NMDAR blockade with APV resulted in a significant
decrease in the mean synapsin immunofluorescence
intensity (at puncta that co-localized with the postsynap-
tic marker PSD95; Figure 1A-C; P < 0.00001; n = 3,376
(control) and 2,979 (+APV) puncta). Similarly, the mean
apparent size of synapsin puncta was decreased by APV
treatment (Figure 1D; P < 0.00001). As illustrated in the
immunoblot shown in Figure 1F, overall synapsin levels
were not significantly decreased by APV treatment (P =
0.28, n = 4 lanes for each condition from 2 experiments,
integrated density of control = 1.15 ± 0.09 × 10
9 and
APV = 1.04 ± 0.035 × 10
9 (Figure 1G)). Consistent with
this, levels of synapsin immunofluorescence measured at
the soma or overall levels in large fields of view were not
significantly changed by NMDAR inhibition (somas: P =
0.1, n = 18 neurons each for control (876 ± 154 arbitrary
units) and APV-treatment (508 ± 91 arbitrary units);
large fields of view: P = 0.86, n = 18 images for each con-
dition, 181 ± 25 and 280 ± 102 arbitrary units for control
and APV-treated, respectively). In addition, the density of
synapsin-positive presynaptic terminals was not signifi-
cantly altered by NMDAR inhibition (Figure 1E; P = 0.29,
n = 28 and 55 images of control and APV-treated axons,
respectively).
To determine whether the observed effects correspond
to a general change in SV proteins, similar experiments
were performed using the integral SV protein, synapto-
physin. Synaptophysin puncta were significantly less
bright in neurons treated with APV than in control neu-
rons (Figure 2A-D; P < 0.0001; n = 650 and 490 puncta
from 45 and 41 axons for control and +APV, respec-
tively). The mean area of synaptophysin-positive puncta
was also decreased by APV treatment (Figure 2E). These
data indicate that NMDAR activation modulates accu-
mulation of synaptophysin at excitatory synapses. When
overall levels of synaptophysin immunofluorescence were
quantified at neuron somas rather than synapses or in
large fields of view, synaptophysin intensity was
unchanged by APV treatment (see Figure 2A,B for exam-
ples; somas: P = 0.1, fluorescence intensity (normalized
to control) = 1.00 ± 0.05 and 1.12 ± 0.05 for n = 25 and
23 somas (control and APV-treated, respectively); overall
fluorescence: P = 0.64, intensity = 1.00 ± 0.04 and 1.04 ±
0.04; for 33 and 34 fields of view for control and +APV,
respectively).
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Page 2 of 12In order to quantify the effects of NMDAR blockade
on presynaptic terminal density, neurons were trans-
fected with GFP to allow us to trace individual axons
and, therefore, quantify the density of synaptophysin
puncta in individual axons. Although there was a small
decrease in the density of synaptophysin puncta in
APV-treated axons when compared to untreated axons,
the observed difference was not statistically significant
(Figure 2F), consistent with previous observations
[26,41,42].
During this stage of development, the vesicular gluta-
mate transporters responsible for loading SVs with
synapsin A B synapsin
(+APV)
intensity
low high
C
0.2
0.6
1.0
s
y
n
a
p
s
i
n
i
n
t
e
n
s
i
t
y *
(p<<0.0001)
(
n
=
3
3
7
6
)
(
n
=
2
9
7
9
)
control
+APV
D
0.2
0.6
1.0
s
y
n
a
p
s
i
n
a
r
e
a *
(p<<0.0001)
(
n
=
2
6
1
)
(
n
=
4
2
6
)
control
+APV
0.2
0.6
1.0 E
control
+APV
s
y
n
a
p
s
i
n
d
e
n
s
i
t
y
(
n
=
2
8
)
(
n
=
5
5
)
(p=0.29)
75 kDa
100 kDa
synapsin
APV:    -       +
F
1
2
x 10
9
s
y
n
a
p
s
i
n
control
+APV
G
Figure 1 NMDAR activation controls accumulation of synapsin at developing excitatory presynaptic terminals. (A, B)
Immunofluorescence images of synapsin in a control neuron (A) and a neuron treated with APV to block NMDAR activation (B). Fluorescence
intensity is pseudo-colored according to the indicated scale. Scale bar: 10 μm. (C) APV treatment decreases accumulation of synapsin at
developing presynaptic terminals. To ensure that presynaptic puncta were synaptic, analysis was limited to synapsin puncta that overlapped with
PSD95. (D) APV similarly decreased the apparent size of synapsin puncta. (E) APV did not significantly decrease the density of synapsin puncta.
Data are presented as mean ± standard error of the mean, normalized to the control mean, and the number of puncta (C-D) and images (E)
measured are indicated on each bar. *, significant difference (P-values are indicated in the figure). (F) Immunoblot demonstrating that overall
levels of synapsin were unchanged by APV treatment. (G) Quantification of synapsin integrated density from immunoblotting. The small
difference in intensity was not significant (P = 0.28).
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Page 3 of 12glutamate undergo a change, with dramatic up-regula-
tion of VGlut1 expression concomitant with decreased
VGlut2 expression [40,43]; therefore, we also tested
whether blockade of NMDARs with APV results in a
decrease in VGlut1 expression at synapses. When neu-
rons were treated with APV from 5 to 8 DIV, VGlut1
intensity at presynaptic terminals decreased significantly
(Figure 2G; P < 0.0001; n = 650 and 490 puncta from
45 and 41 axons of control and APV-treated neurons,
respectively). Therefore, the level of VGlut1 at synapses
is also modulated by activation of NMDARs. These data
demonstrate, for the first time, that NMDAR activation
regulates accumulation of multiple SV proteins during
excitatory presynaptic development.
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Figure 2 NMDAR activation controls accumulation of multiple synaptic vesicle proteins at developing excitatory presynaptic terminals.
(A, B) Immunofluorescence images of synaptophysin in a control neuron (A) and a neuron treated with APV to block NMDA receptors (B).
Fluorescence intensity is pseudo-colored according to the indicated scale. (C) Higher magnification immunofluorescence images of
synaptophysin (arrows) in a GFP-transfected axon (white outline). Left, control neuron; right, neuron treated with APV to block NMDAR activation.
Scale bars: 10 μm. (D, E) APV treatment decreased accumulation of synaptophysin at developing presynaptic terminals. Both the intensity (D)
and apparent sizes (E) of synaptophysin puncta were decreased upon APV exposure. (F) APV did not change presynaptic terminal density. (G)
Blockade of NMDA receptors with APV decreased the expression of VGlut1 at terminals. Data are presented as normalized mean ± standard error
of the mean, and the number of puncta (D, E, G) and axons (F) measured are indicated on each bar. *, significant difference (P-values are
indicated in the figure).
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Page 4 of 12NMDAR activation controls accumulation of synaptic
vesicle proteins at synapses that lack postsynaptic
NMDARs
Since postsynaptic NMDARs are already present at nas-
cent synapses within minutes to hours of axo-dendritic
contact [44], we next tested whether postsynaptic signal-
ing mediates the observed effects of NMDAR activation.
To test whether postsynaptic signaling is required,
hemi-synapses were formed that contained presynaptic
terminals but lacked postsynaptic densities. These hemi-
synapses were formed by taking advantage of the well-
established observation that contact between an axon
and a neuroligin-expressing non-neuronal cell is suffi-
cient to induce presynaptic terminal assembly, even in
the absence of dendritic contact [45]. For this assay,
HEK-293 cells were transfected with neuroligin. Co-
transfection of the HEK-293 cells with actin-GFP
allowed visualization of neuroligin-expressing cells,
including their lamellipodial extensions. The neuroligin-
expressing cells were placed into contact with axons of
6t o7D I Vn e u r o n s ,a n dh a l fo ft h ec o - c u l t u r e sw e r e
treated with APV (0.1 mM). After 24 to 48 h, cells were
fixed and immunolabeled. Presynaptic puncta induced
by neuroligin were identified by overlap with actin-GFP
in the contacting HEK-293 cell, tau-1 in the axon and
the absence of PSD95, to indicate the absence of a post-
synaptic partner (Figure 3A).
Surprisingly, when neurons were treated with APV,
the intensities of synapsin puncta associated with neuro-
ligin-expressing cells decreased significantly (Figure 3B;
P < 0.0001; n = 750 (control) and 532 (+APV) puncta).
Importantly, treatment with APV did not significantly
alter the expression of neuroligin (P > 0.05; n = 63 (con-
trol) and 66 (+APV) HEK-293 cells; data not shown).
These data demonstrate that postsynaptic receptor acti-
v a t i o ni sn o tr e q u i r e df o rN M D A R - d e p e n d e n tm o d u l a -
tion of excitatory presynaptic development.
Direct activation of NMDARs increases synaptic vesicle
protein accumulation
To determine whether accumulation of presynaptic pro-
teins can be enhanced by increased NMDAR activation,
neurons were treated for 24 h with NMDA, a highly selec-
tive NMDAR agonist. Synapsin immunofluorescence was
A
B
control
+APV
0.2
0.6
1.0
s
y
n
a
p
s
i
n
i
n
t
e
n
s
i
t
y
(
n
 
=
 
7
5
0
)
(
n
 
=
 
5
3
2
)
*
(p<<0.0001)
actin-GFP
and tau-1 synapsin
control
NMDA 0
0.5
1.0
s
y
n
a
p
s
i
n
i
n
t
e
n
s
i
t
y
1.5
(
n
=
1
4
3
)
(
n
=
7
3
)
C
Figure 3 NMDAR-dependent accumulation of synaptic vesicle proteins at developing presynaptic terminals is independent of
postsynaptic NMDARs and bi-directional. (A) Synapsin accumulates at presynaptic terminals induced by contact with neuroligin-expressing
HEK-293 cells. The neuroligin-expressing cell is identified by co-expression of actin-GFP (green) and is outlined in both panels (white). Axons
were labeled with tau-1 antibodies to identify contacts and are visible in the left panel (green, highlighted with yellow dashed lines). Induced
synapsin puncta are indicated by arrows (right panel). The left panel also shows the overlay of the synapsin (red) and PSD95 (blue). PSD95 label
does not co-localize with induced synapsin puncta. Scale bar: 10 μm. (B) Accumulation of synapsin is decreased by APV at presynaptic terminals
that lack postsynaptic partners. (C) Direct activation of NMDARs via treatment with NMDA (0.015 mM for 24 h) increased the fluorescence
intensity of synapsin puncta (P < 0.0001). Data are normalized to the control mean and presented as normalized mean ± standard error of the
mean. The numbers of puncta quantified for each condition are indicated on the plots in (B, C). *, significant difference (P-values are indicated in
the figure).
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Page 5 of 12imaged and quantified at presynaptic terminals induced by
contact with neuroligin-expressing HEK-293 cells. Direct
activation of NMDARs yielded an increase in the intensity
of synapsin fluorescence (Figure 3C; P < 0.0001; n = 143
(control) and 73 (NMDA-treated) puncta). These data
demonstrate that presynaptic protein accumulation is bi-
directionally controlled by activation of NMDARs.
Activation of NMDARs regulates accumulation of active
zone proteins at presynaptic terminals
SV and AZ proteins are delivered to developing
synapses via distinct precursor vesicles [1]. Therefore,
we next tested whether the observed changes in SV pro-
tein accumulation were due to either a specific change
in SVs or a more general change in presynaptic terminal
development. To distinguish between these possibilities,
accumulation of the AZ matrix protein piccolo was
measured in similar experiments (Figure 4A). When
neurons were treated with APV for 24 to 48 h at 6 to 7
DIV, the mean intensity of piccolo puncta was signifi-
cantly decreased in APV-treated neurons (P < 0.0001; n
= 1,103 and 807 puncta for control and +APV, respec-
tively). When analysis was limited to piccolo puncta that
exhibited colocalization with PSD95, similar decreases in
piccolo intensity were observed (Figure 4B; P < 0.00001;
n = 840 and 618 puncta for control and +APV, respec-
tively). These data demonstrate that NMDAR activation
controls accumulation of both AZ and SV proteins at
developing synapses.
Next, we determined whether NMDAR-dependent regu-
lation of AZ development is also independent of postsy-
naptic signaling. To do so, axons were contacted with
HEK-293 cells expressing neuroligin and actin-GFP to
generate synapses that lack postsynaptic NMDARs, as
described above for SV proteins (Figure 4C). The intensity
of piccolo was significantly decreased at presynaptic term-
inals that were induced by contact with neuroligin (Figure
4D; P < 0.0001; n = 874 (control) and 706 (+APV) puncta).
The mean size of piccolo puncta was also decreased at
these presynaptic terminals (Figure 4D; P < 0.01, n = 874
(control) and 706 (+APV) puncta). These results indicate
that NMDARs control accumulation of AZ proteins dur-
ing excitatory presynaptic terminal development, even in
the absence of retrograde signals from postsynaptic part-
ners. Together, our data are consistent with the hypothesis
that NMDAR activation regulates the assembly of multiple
classes of synaptic proteins at developing excitatory presy-
naptic terminals.
Blockade of non-NMDA glutamate receptors but not
network activity decreases presynaptic protein
accumulation
In addition to NMDA receptors, cortical neurons
express AMPA (a-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid) and kainate receptors. To
determine whether the effects of NMDAR activation
were limited to NMDARs, neurons were treated with
the AMPA/kainate receptor blocker CNQX (6-cyano-7-
nitroquinoxaline-2,3-dione; 0.025 mM) as described
above for APV. Then synapsin immunofluorescence was
imaged and quantified at presynaptic terminals induced
by contact with HEK-293 cells expressing neuroligin.
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Figure 4 NMDAR activation controls accumulation of active
zone proteins at developing excitatory presynaptic terminals.
(A) Fluorescence images of the AZ protein piccolo (red, left panel;
white, right panel) in young axons (tau-1, green). Piccolo was at
synapses since it co-localized with PSD95 (blue). Scale bars: 10 μm.
(B) Treatment with APV decreased accumulation of piccolo at
presynaptic terminals that co-localized with PSD95. (C) Piccolo
(arrows; red, left panel; white, right panel) is recruited to presynaptic
terminals induced by contact with neuroligin and actin-EGFP-
expressing HEK-293 cells (green and outline). These piccolo puncta
did not co-localize with PSD95 (blue). Axons were labeled with tau-
1 antibodies (green) to identify contacts. (D) APV decreased
accumulation of piccolo at presynaptic terminals that lack
postsynaptic partners (left). APV also decreased the apparent sizes of
piccolo puncta (right). Data are presented as normalized mean ±
standard error of the mean, and the number of puncta quantified
are indicated on each bar. *, significant difference (P-values are
indicated in the figure).
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Page 6 of 12Upon treatment with CNQX, synapsin immunofluores-
cence was decreased (Figure 5A; n = 634 (control) and
536 (+CNQX) puncta). Similar to what was observed
upon NMDAR blockade, the apparent size of synapsin
puncta was also decreased (Figure 5B; n = 344 (control)
and 241 (+CNQX) puncta) when non-NMDA glutamate
receptors were inhibited. When neurons were treated in
p a r a l l e lw i t hA P V( 0 . 1m M ) ,C N Q X( 0 . 0 2 5m M ) ,o r
APV plus CNQX (0.1 and 0.025 mM, respectively), all
three treatments caused similar decreases in synapsin
fluorescence (Figure 5C; n = 261 (untreated), 426 (APV-
treated), and 302 (APV+CNQX-treated) puncta). APV
and CNQX treatment were not additive. In addition, the
effects of CNQX on synapsin immunofluorescence
could be reversed by treatment with NMDA (0.015 mM;
Figure 5D; n = 162 (+CNQX) and 69 (+CNQX and
NMDA) puncta). Interestingly, treatment with the
sodium channel blocker tetrodotoxin (TTX; 0.001 mM)
did not alter synapsin accumulation at presynaptic term-
inals (Figure 5E; n = 449 (control) and 366 (TTX-trea-
ted) puncta), suggesting that the observed effects of
glutamate receptor activity are not a result of decreased
action potential-evoked activity.
NMDAR-dependent control of presynaptic protein
accumulation is independent of glial glutamate
Previous reports have shown that glia can release gluta-
mate [46-49]. Therefore, the effects of NMDAR activation
on presynaptic development could be due to presynaptic
terminals sensing glutamate released from glia. To test
this, neurons were cultured without either a glial mono-
layer or glial conditioning of medium then treated with
APV and immunolabeled to quantify SV protein accumu-
lation, as described above. In these cultures, inhibition of
NMDAR activation with APV resulted in a decrease in the
intensity of synapsin labeling at presynaptic terminals
(Figure 6A,B; P < 0.00001; n = 1,267 (control) and 1,183
(+APV) presynaptic terminals). The average apparent size
of synapsin puncta was also smaller upon inhibition of
NMDARs (Figure 6C; P < 0.00001; n = 1,267 (control) and
1,183 (+APV) puncta). Similar to what was observed when
neurons were grown on top of glia, the density of synapsin
puncta was unchanged by APV (Figure 6D; P =0 . 6 8 ,n=
26 and 50 images of control and +APV axons, respec-
tively). Non-neuronal cells were only present in these cul-
tures at a density of approximately 3.7 × 10
-12/mm
2,a n d
only fields of view that lacked any glia were imaged for
quantification of synapsin; therefore, glia could not have
released glutamate near the quantified synapses. While it
remains formally possible that the few glia present in the
cultures could have contributed to ambient glutamate
levels, on average les than 900 glia were present for each 1
ml of culture medium, making it unlikely that glutamate
released by these glia was a major source for NMDAR
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Figure 5 Accumulation of synaptic vesicle proteins is decreased
by blockade of non-NMDA glutamate receptors but not action
potential activity in the entire network. (A) Treatment of neurons
with the AMPA/kainate receptor inhibitor CNQX resulted in decreased
synapsin immunofluorescence intensity, similar to that observed with
APV. (B) The apparent size of synapsin puncta was also decreased by
CNQX exposure. (C) The effects of APV and CNQX on synapsin
accumulation were not additive. Although APV application resulted in a
significant decrease in synapsin intensity (P << 0.0001), addition of APV
plus CNQX yielded a decrease that is not quantitatively different from
the decrease induced by APV application alone (P = 0.15). Similarly, the
effect of APV plus CNQX application on the apparent size of synapsin
puncta was also not different from that observed with treatment with
APV alone (data not shown, P =0 . 2 7 ) .(D) Treatment of neurons with
NMDA reversed the effects of CNQX on the intensity of synapsin
puncta. (E) Treatment of neurons with TTX did not significantly
decrease the intensity of synapsin puncta (P = 0.079). Data are
presented as the mean ± standard error of the mean and are
normalized to control values. The numbers of puncta measured for
each condition are indicated on the plots. N.s., not significant. *, highly
significant difference and **, significant difference (P-values are
indicated in the figure).
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Page 7 of 12activation. These data suggest that glutamate released by
glia is not required for activation of NMDARs during
development of presynaptic terminals.
Discussion
The mechanisms that control accumulation of SV and AZ
proteins at developing presynaptic terminals remain
poorly understood. Here, we tested whether NMDAR
activity plays an important role in presynaptic terminal
development. We showed that activation of NMDA recep-
tors regulates accumulation of both SV and AZ proteins at
developing synapses. By imaging contacts between axons
and HEK-293 cells that express the synaptogenic protein
neuroligin, we were able to study presynaptic development
in the absence of postsynaptic signaling. Using this
approach, we demonstrated that activation of NMDARs
controls accumulation of both SV and AZ proteins at
developing presynaptic terminals, independent of postsy-
naptic receptor activation. Although it is still possible that
postsynaptic NMDAR signaling can also contribute to this
process, the magnitude of the NMDAR-dependent change
in synaptic protein accumulation at terminals that lack
postsynaptic NMDARs was sufficient to explain the effects
of blockade of all NMDARs. Importantly, our results using
neuroligin-expressing HEK-293 cells also argue against
indirect effects of axon and dendrite growth since presy-
naptic terminals were induced in regions of axon that had
already grown and dendrites were not involved. The
effects observed here could be due to either changes in
recruitment of presynaptic proteins to presynaptic term-
inals or changes in transcription, translation or stability of
synaptic proteins. We did not observe overall changes in
the levels of synapsin or synaptophysin, but contributions
from local changes in synthesis or stability are still
possible.
I nc o n t r a s tt oap l e t h o r ao fs t u d i e so nt h er o l eo f
activity in control of synapse density and postsynaptic
receptor recruitment [10,12,23], few studies have
focused on control of important aspects of presynaptic
development, such as the accumulation of synaptic pro-
teins at presynaptic terminals. Immunoblotting of
VGlut1 knockout mouse hippocampus showed that
overall levels of SV proteins were decreased [40]. Our
data show a similar reduction of SV proteins in neocor-
tical neurons and extend these observations to demon-
strate that changes in SV protein expression occur at
the level of individual synapses and are accompanied by
decreases in AZ proteins.
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Figure 6 NMDAR-dependent accumulation of synaptic vesicle proteins does not depend on interactions with glia. (A) Images of
synapsin immunofluorescence (arrows) at presynaptic terminals of neurons grown in the absence of glia. Images are pseudo-colored such that
the highest intensities are white while the lowest are black, as indicated by the intensity scale below the images. Top, control neuron; bottom,
APV-treated neuron. (B, C) Synapsin intensity and apparent size at presynaptic terminals were significantly reduced when neurons were treated
with APV even when glia were not present. (E) Similar to what was observed in cultures grown in contact with glia, the density of synapsin-
positive presynaptic puncta remained unchanged. Data are presented as normalized mean ± standard error of the mean, and the number of
puncta measured are indicated on the plot. *, significant difference (P-values are indicated in the figure).
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four possible mechanisms (Figure 7). First, activation of
postsynaptic NMDARs could induce transmission of a
retrograde trans-synaptic signal sent from the postsy-
naptic dendrite to its presynaptic partner. Second, the
NMDARs in the dendrites of a given neuron could sig-
nal transneuronally to the axon of the same neuron to
control presynaptic development. Third, activation of
presynaptic NMDARs by glutamate released from presy-
naptic terminals could be responsible for the observed
effects. Fourth, glia could release glutamate that acti-
vates NMDARs on the presynaptic neuron. Our data
indicate that retrograde signaling across nascent
synapses is not required for NMDAR-dependent regula-
tion of presynaptic development. Our results also
demonstrate that glutamate derived from glia is not
required. Therefore, our results are most consistent with
a cell autonomous action of NMDARs, mediated by pre-
synaptic NMDARs or transneuronal signaling.
Presynaptic NMDA receptors (preNMDARs) are pre-
sent in the developing cerebral cortex [30,50], with the
highest levels found during the peak of excitatory
synapse formation [51]. These receptors are already
functional at P7, the earliest age tested [51]. Therefore,
preNMDARs are well-positioned to play a role in regu-
lating excitatory synapse formation in the cerebral cor-
tex. Although the function of preNMDARs in synaptic
plasticity and short-term changes in neurotransmitter
release is beginning to be understood [31], the conse-
quences of prolonged changes in preNMDAR activity
and their potential role in synapse development remain
unknown. If preNMDARs facilitate accumulation of SV
and AZ proteins at nascent synapses, this mechanism
could ensure that functional presynaptic terminals are
preferentially made and maintained, even in the absence
of postsynaptic responses. This is particularly important
given the prevalence of postsynaptically silent synapses
during circuit development [52,53]. Interestingly, pre-
NMDAR activation could represent a general mechan-
ism for quality control during development of excitatory
synapses since preNMDARs have been found in neurons
from visual and somatosensory neocortex, entorhinal
cortex, hippocampus, amygdala, cerebellum and spinal
cord [30,50]. To test this new model, it will be impor-
tant to develop methods for selectively activating or
blocking preNMDARs for extended periods of time
without affecting postsynaptic NMDARs [30].
How might activation of preNMDARs control synaptic
protein accumulation? One possibility is that calcium
influx via preNMDARs could enhance recruitment and
stabilization of SV and AZ proteins. Cytoplasmic cal-
cium can control trafficking of SV proteins, increasing
pausing of SV protein transport at sites of synapse for-
mation [8]. This may favor accumulation of SV proteins
at nascent presynaptic terminals. It is not yet clear
whether AZ protein delivery is similarly regulated by
intracellular calcium.
Transneuronal signaling is also possible since recent
evidence suggests that postsynaptic activity can signal to
the axon, independent of action potential generation
[34-38]. In cortical layer 5 pyramidal neurons (ages P13
to P19), activation of dendritic NMDARs may be
responsible for cell-autonomous NMDAR-dependent
facilitation of neurotransmitter release [34]. In this
study, direct activation of axonal NMDARs was not
observed, and it was suggested that sub-threshold post-
synaptic NMDAR activity could affect presynaptic
release machinery via electrical signaling. It is possible
that similar mechanisms are responsible for the changes
in presynaptic protein accumulation that we have
observed. In the experiments described here, TTX treat-
ment did not mimic NMDAR blockade, so the observed
effects of NMDAR inhibition were probably not due to
postsynaptic NMDARs
presynaptic NMDARs
glia
transneuronal signal
retrograde signal
glial signal
autoreceptor signal
NMDARs
(1)
(2)
(3)
(4)
Figure 7 Models of presynaptic terminal development by
activation of NMDARs. NMDAR activation by glutamate could
regulate presynaptic development via at least four mechanisms: (1)
glutamate released from presynaptic terminals could activate
postsynaptic NMDARs, then postsynaptic neurons could release a
retrograde signal that controls presynaptic development; (2)
activation of postsynaptic NMDARs could induce transmission of a
transneuronal signal, regulating presynaptic development in the
activated neuron; (3) glutamate released from presynaptic terminals
could activate presynaptic autoreceptors to cell-autonomously
regulate presynaptic development; (4) glia could release glutamate
to activate NMDARs and regulate presynaptic development.
Mechanisms 1 and 2 are mediated by activation of postsynaptic
NMDARs, while mechanisms 3 and 4 are mediated by presynaptic
NMDARs. The data presented here are most consistent with
mechanisms 2 and 3 since NMDAR activation controlled presynaptic
protein accumulation in the absence of glia and at synapses that
lacked postsynaptic NMDARs.
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mechanisms for cell-autonomous control of presynaptic
development by postsynaptic receptors are possible. For
example, dendritic NMDAR activation could induce sig-
nal transduction that ultimately alters second messenger
levels within the axon, and this second messenger could
control synaptic protein accumulation. Alternatively,
dendritic NMDAR-dependent signals could control the
trafficking of presynaptic proteins out of the soma and
into the axon.
Coincident with the period of intense synapse forma-
tion, several important aspects of visual cortical recep-
tive fields are established, including retinotopy, ocular
dominance and orientation selectivity. Activity within
the visual cortex contributes to establishment of these
receptive field properties [54]. NMDAR blockade inter-
feres with development of receptive field properties in
the visual system [55-57]. Therefore, control of presy-
naptic development by NMDARs could ultimately play a
role in establishing receptive fields.
Conclusions
Here, we have demonstrated that activation of NMDARs
controls accumulation of SV and AZ proteins at devel-
oping presynaptic terminals. This regulation occurs even
in the absence of retrograde signaling from postsynaptic
NMDARs or glia and may also involve activation of
AMPA/kainate receptors. We propose a novel model for
presynaptic development in which NMDAR activation
cell-autonomously regulates presynaptic terminal assem-
bly. This could provide a feed-back mechanism capable
of promoting development of active presynaptic term-
inals, even at silent synapses, and could contribute to
activity-dependent development and refinement of corti-
cal receptive field properties.
Materials and methods
All studies were conducted with an approved protocol
f r o mt h eC a s eW e s t e r nR e s e r v eU n i v e r s i t yI n s t i t u t i o n a l
Animal Care and Use Committee, in compliance with
National Institutes of Health guidelines for care and use
of experimental animals.
Cell cultures and transfection
Cell culture reagents were from Invitrogen (Grand
Island, NY, USA) and other chemicals were from Sigma
(St. Louis, MO, USA) unless otherwise indicated. Neu-
rons were dissociated from visual cortices of 0- to 3-
day-old Long Evans rats [58] then plated (3 to 4 × 10
4
cells/ml) on a confluent monolayer of cortical astrocyes
in Neurobasal-A medium with glutamax and B27 sup-
plement. Astrocytes were grown on coverslips coated
with collagen and poly-L-lysine and maintained in Mini-
mum Essential Medium containing glutamax, 10% fetal
calf serum, glucose (0.6%), N2 and penicillin-streptomy-
cin. At 2 to 4 DIV, cultures were treated with anti-mito-
tic (5’fluoro-2’-deoxy-uridine/uridine). HEK-293 cells
were maintained in DMEM with 10% fetal calf serum
and penicillin-streptomycin. Neurons were transfected
at 5 to 7 DIV using calcium-phosphate [59,60] or lipo-
fectamine 2000 [58].
For growth in the absence of glia, neurons were plated
directly on coverslips coated with 1 mg/ml high molecular
weight poly-L-lysine. Glia were present at very low num-
bers in these preparations, and addition of anti-mitotic
prevented their proliferation. At the time of imaging, non-
neuronal cells were present at a density of approximately
3.7 × 10
12 mm
2, as determined by the absence of neuronal
markers, such as bIII-tubulin and tau. For these experi-
ments, images were only collected in regions that lacked
non-neuronal cells.
Presynaptic terminal induction assay
HEK-293 cells were co-transfected with hemagglutinin-
tagged neuroligin and actin-EGFP. HEK-293 cells were
removed from their dishes using enzyme-free dissocia-
tion medium (Invitrogen) 12 to 24 h after transfection,
washed in neuronal medium, then added to neuronal
cultures (6 to 7 DIV) at 3 to 5 × 10
4 cells per 18 mm
coverslip. APV (0.1 mM), CNQX (0.025 mM), TTX
(0.001 mM) or N-methyl-D-aspartic acid (NMDA; 0.015
mM) were added 10 to 60 minutes later. After 24 to 48
h, cells were fixed and immunolabeled.
Immunofluorescence and confocal imaging
At 8 to 9 DIV, cells were fixed (15 minutes, 25°C) with 4%
paraformaldehyde in 0.1 M PBS containing 4% sucrose,
permeabilized with 0.2% Triton X-100 in PBS, and blocked
with 10% horse serum or bovine serum albumin in PBS.
Antibody labeling was in 3% horse serum or bovine serum
albumin for at least 1 h at 25°C or overnight at 4°C. Cover-
slips were mounted in fluoromount (Fisher (Waltham,
MA, USA)) containing 1,4-diazabicyclo(2.2.2)octane. Pri-
mary antibodies were: mouse anti-synaptophysin (Sigma),
rabbit anti-synapsin (Millipore-Chemicon (Billerica, MA,
USA), Synaptic Systems (Goettingen, Germany)); rabbit
anti-piccolo, rabbit anti-VGlut2, guinea pig anti-tau-1
(Synaptic Systems); guinea pig anti-VGlut1, chicken anti-
GFP (Chemicon); and mouse anti-PSD95 (NeuroMab
(Davis, CA, USA)). Secondary antibodies were Alexa-fluor
conjugates (Invitrogen).
Imaging was performed on a Nikon C1 Plus confocal
system on a Nikon Ti-E inverted microscope with
488Ar, 543HeNe and 633HeNe lasers and 40 × 1.0NA
and 0.95NA objectives. Excitatory neurons were chosen
for analysis based on morphology and/or expression of
VGlut1. Three-dimensional image stacks were collected
using EasyC1 software (Nikon) with 2 × Kalman
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pixel depth. Each channel was imaged separately to
avoid bleed-through. Imaging parameters were opti-
mized to maintain fluorescence within the linear range
and maximize intensity resolution. Settings were kept
constant for all conditions to be compared within each
experiment. Although gains were generally very similar
across experiments for any given antibody label, gains
were set independently for each independent experi-
ment. Overall fluorescence was measured over 3,172 to
12,688 μm
2 for each field of view.
Immunoblotting
Cultures were lysed in 1% Triton X-100 (in 50 mM Hepes,
pH 7.4, 150 mM NaCl, 1 mM EDTA, protease inhibitor
cocktail) on ice then incubated at room temperature in
Laemmli sample buffer. Equal protein was loaded on Tris-
glycine gels. Blots were probed with rabbit anti-synapsin
(1:400) followed by goat anti-rabbit-horse radish peroxi-
dase. Equal loading was confirmed by probing the same
blot with MAP2 antibody. Chemiluminescence was
recorded and quantified using an AlphaImager HP system
(Alpha Innotech (Santa Clara, CA, USA)). All signals were
below saturation and within the linear range of the
detector.
Analysis
Automated image analysis was performed using custom
written macros in ImageJ. Maximum intensity Z-projec-
tions were made then background-subtracted using a
rolling ball algorithm. GFP images were used to select
the region of interest (axon or HEK-293 cell). Fluores-
cent puncta were automatically selected in the region of
interest, and their intensities, areas and densities were
measured. Analysis of apparen ts i z ew a so fi m a g e sc o l -
lected at 80 nm/pixel. It is worth noting that the actual
sizes of AZs and clusters of SVs are near or below our
spatial resolution limit; therefore, one cannot conclu-
sively separate changes in intensity and size. Measure-
ments were transferred to Matlab for quantification
using custom-written functions. To combine the data
obtained from multiple experiments, the data were nor-
malized. For each independent experiment, data were
normalized by dividing by the mean of the control
values of that experiment. Then normalized values were
pooled to perform statistical analysis on the entire popu-
lation of presynaptic terminals. Data are presented as
normalized mean ± standard error of the mean. Statisti-
cal tests were ANOVA or Wilcoxon rank sum test.
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